Akari Therapeutics Plc
AKTXDrugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
1
Next Catalyst
Aug 12, 2026
4wMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Akari Therapeutics Plc's drug pipeline?→
CatalystAlert tracks 2 drug candidates in Akari Therapeutics Plc's (AKTX) pipeline across Phase 3, Phase 2. Its lead program is rVA576 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Akari Therapeutics Plc's next FDA catalyst?→
Akari Therapeutics Plc's (AKTX) next tracked catalyst is a Earnings expected August 12, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track AKTX biotech catalysts?→
Add AKTX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Akari Therapeutics Plc's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.